在α-synuclein小鼠中的多巴胺基损失和包容体形成:对神经退行性疾病的影响
E Masliah1, E Rockenstein, I Veinbergs
1Department of Neurosciences, Department of Pathology, University of California San Diego, La Jolla, CA 92093-0624, USA. emasliah@ucsd.edu
概括
这项研究表明,神经元中积累的α-synuclein蛋白质会导致脑细胞损伤和运动缺陷. 这些发现表明,α-synuclein在帕金森病的发病过程中起着关键作用.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔法同核素是一种突触蛋白,涉及神经退行性疾病.
- 它在疾病发病过程中的确切作用仍然不完全理解.
研究的目的:
- 为了研究大脑中野生类型α-synuclein积累的功能作用.
- 为了确定α-synuclein聚合是否有助于神经元功能障碍和运动缺陷.
主要方法:
- 产生表达野生类型人类α-synuclein的转基因小鼠.
- 对神经元内含的α-synuclein和ubiquitin免疫活性进行分析.
- 神经元沉积物的超结构检查 (内核和细胞质).
- 对多巴胺终端完整性和运动功能的评估.
主要成果:
- 人类α-synuclein的神经表达导致了α-synuclein和ubiquitin在新皮质,海马体和黑色物质中逐渐积累.
- 超结构分析证实了核内和细胞质内含物.
- 观察到的变化与基底质中多巴氨基终端的损失以及显著的运动障碍相关.
结论:
- 野生类型α-synuclein的积累可以诱导神经元病理和功能缺陷.
- 这些发现强烈表明,α-synuclein聚合在帕金森病和相关的synucleinopathies的发展中起着因果作用.
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...


